Tag: ONL Therapeutics

Browse exclusive Tags!

ONL Therapeutics Enrolls 135+ Patients in Phase 2 Trial of ONL1204 for Retinal Disease: Topline Data Expected 1H2024, US

ONL Therapeutics achieves milestone in Phase 2 trial of ONL1204 Ophthalmic Solution for retinal disease - 135 patients enrolled in 4 months.

Popular

Subscribe

spot_imgspot_img